Literature DB >> 24592101

Two patients with marginal symptoms showing hyperthecosis at the edge of malignancy: Presentation of two cases.

Sinan Beksac1, Ilker Selçuk1, Gökhan Boyraz1, Güneş Güner2, Mert Turgal1, Alp Usubutun2.   

Abstract

It is important to define the aetiology of increased levels of androgens in women. Ovarian stromal hyperplasia (OSH) and ovarian hyperthecosis (OHT) are non-neoplastic pathologies. They show the excess of androgen production and have a wide clinical range like hirsutism, virilisation, abnormal menses, obesity, hypertension and insulin resistance. Ovarian stromal hyperplasia and hyperthecosis are commonly seen in postmenopausal women and generally involve both ovaries. Laboratory testing is the gateway; testosterone and dehydroepiandrosterone sulphate (DHEA-S) are the first hormones that should be measured. OSH and OHT could also be a reason for endometrial malignancy by unopposed oestrogenic status. Hyperthecosis must be differentiated from several other diseases, especially malignant conditions, and the treatment for postmenopausal women should be bilateral oophorectomy.

Entities:  

Keywords:  Hyperthecosis; hirsutism; malignancy; menopause

Year:  2013        PMID: 24592101      PMCID: PMC3928419          DOI: 10.5152/jtgga.2013.88964

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  14 in total

1.  [Clinical, hormonal and histological features in ovarian stromal hyperthecosis].

Authors:  M V Abuladze; N G Sharabidze
Journal:  Georgian Med News       Date:  2006-10

Review 2.  How should postmenopausal androgen excess be evaluated?

Authors:  Micol S Rothman; Margaret E Wierman
Journal:  Clin Endocrinol (Oxf)       Date:  2011-08       Impact factor: 3.478

3.  [Ovarian stromal hyperthecosis and concurrent endometrial carcinoma of the uterus].

Authors:  J Kuntscherová; M Michal; R Nováková; H Jahnová
Journal:  Ceska Gynekol       Date:  2000-03

4.  New onset alopecia and hirsutism in a postmenopausal women.

Authors:  Annette Bühler-Christen; Verena Tischler; Pierre-André Diener; Michael Brändle
Journal:  Gynecol Endocrinol       Date:  2009-05       Impact factor: 2.260

5.  Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer.

Authors:  M Nagamani; E V Hannigan; T V Dinh; C A Stuart
Journal:  J Clin Endocrinol Metab       Date:  1988-07       Impact factor: 5.958

6.  Virilization due to ovarian hyperthecosis in a postmenopausal woman.

Authors:  C van Heyningen; I A MacFarlane; M J Diver; C Muronda; D Tuffnell
Journal:  Gynecol Endocrinol       Date:  1988-12       Impact factor: 2.260

7.  Serum testosterone concentrations in the evaluation of androgen-producing tumors.

Authors:  C I Friedman; G E Schmidt; M H Kim; J Powell
Journal:  Am J Obstet Gynecol       Date:  1985-09-01       Impact factor: 8.661

8.  Androgen and estrogen formation in women with ovarian hyperthecosis.

Authors:  J Aiman; C D Edman; R J Worley; F Vellios; P C MacDonald
Journal:  Obstet Gynecol       Date:  1978-01       Impact factor: 7.661

Review 9.  Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis".

Authors:  P E Hughesdon
Journal:  Obstet Gynecol Surv       Date:  1982-02       Impact factor: 2.347

Review 10.  Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

Authors:  Kathryn A Martin; R Jeffrey Chang; David A Ehrmann; Lourdes Ibanez; Rogerio A Lobo; Robert L Rosenfield; Jerry Shapiro; Victor M Montori; Brian A Swiglo
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.